DRW Securities’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$438K Sell
3,207
-817
-20% -$114K 0.01% 673
2025
Q4
$494K Sell
4,024
-855
-18% -$104K 0.01% 471
2025
Q3
$540K Buy
+4,879
New +$555K 0.01% 572
2025
Q2
Sell
-3,865
Closed -$433K 1162
2025
Q1
$433K Buy
+3,865
New +$399K 0.01% 361
2024
Q2
Sell
-8,356
Closed -$612K 566
2024
Q1
$612K Buy
+8,356
New +$643K 0.02% 213
2023
Q4
Sell
-3,869
Closed -$290K 375
2023
Q3
$290K Sell
3,869
-398
-9% -$30.6K 0.01% 271
2023
Q2
$329K Buy
+4,267
New +$340K 0.01% 244
2021
Q3
Sell
-3,998
Closed -$275K 301
2021
Q2
$275K Buy
+3,998
New +$267K 0.01% 236
2020
Q4
Sell
-5,656
Closed -$357K 159
2020
Q3
$357K Buy
+5,656
New +$392K 0.02% 113
2020
Q2
Sell
-6,923
Closed -$518K 231
2020
Q1
$518K Sell
6,923
-1,406
-17% -$97.2K 0.02% 146
2019
Q4
$541K Buy
+8,329
New +$542K 0.02% 119
2018
Q1
Sell
-18,312
Closed -$1.31M 293
2017
Q4
$1.31M Buy
+18,312
New +$1.39M 0.14% 96
2016
Q2
Sell
-17,500
Closed -$1.61M 80
2016
Q1
$1.61M Buy
+17,500
New +$1.58M 0.1% 33
2015
Q4
Sell
-51,000
Closed -$5.01M 87
2015
Q3
$5.01M Buy
+51,000
New +$5.66M 0.55% 9
2015
Q1
Sell
-65,000
Closed -$6.13M 120
2014
Q4
$6.13M Buy
+65,000
New +$6.72M 0.7% 23
2014
Q1
Sell
-73,259
Closed -$5.5M 167
2013
Q4
$5.5M Buy
73,259
+53,659
+274% +$3.74M 0.23% 18
2013
Q3
$1.35M Buy
+19,600
New +$1.17M 0.1% 54

Other funds holding GILD

DRW Securities's GILD Position: Q1 2026 in Review

DRW Securities reduced its Gilead Sciences (GILD) stake by 20% in Q1 2026, selling an estimated $114K and leaving 3,207 shares worth $438K. The position accounts for 0.01% of the portfolio, ranked #673.

DRW Securities first reported a position in GILD in Q3 2013 and has held it in 17 quarters since. The position peaked at $6.13M in Q4 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • DRW Securities held 3,207 shares of Gilead Sciences worth $438K as of Q1 2026.
  • DRW Securities sold 817 Gilead Sciences shares in Q1 2026, an estimated $114K.
  • Gilead Sciences made up 0.01% of DRW Securities's portfolio in Q1 2026, its #673 holding.
  • DRW Securities first reported a position in Gilead Sciences in Q3 2013 and has held it in 17 quarters since.
  • DRW Securities's Gilead Sciences position peaked at $6.13M in Q4 2014.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.